Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(17%)
Results Posted
60%(3 trials)

Phase Distribution

Ph phase_1
1
17%
Ph phase_3
1
17%
Ph phase_4
1
17%
Ph phase_2
1
17%
Ph not_applicable
1
17%

Phase Distribution

1

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(5)

Detailed Status

Completed5
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (20.0%)
Phase 21 (20.0%)
Phase 31 (20.0%)
Phase 41 (20.0%)
N/A1 (20.0%)

Trials by Status

completed583%
recruiting117%

Recent Activity

1 active trials
Showing 5 of 6
recruitingphase_2

Treatment Interrupts Depression Early

NCT05002309
completednot_applicable

Comparison of Depression Identification After Acute Coronary Syndrome: Quality of Life and Cost Outcomes

NCT01993017
completedphase_4

Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older Adults

NCT01973283
completed

Medication Treatment for Depression in Nursing Home Residents

NCT00076622
completedphase_3

Antidepressant Medication for Reducing HIV Risk Behavior in Depressed Intravenous Drug Users

NCT00228007
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05002309Phase 2

Treatment Interrupts Depression Early

Recruiting
NCT01993017Not Applicable

Comparison of Depression Identification After Acute Coronary Syndrome: Quality of Life and Cost Outcomes

Completed
NCT01973283Phase 4

Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older Adults

Completed
NCT00076622

Medication Treatment for Depression in Nursing Home Residents

Completed
NCT00228007Phase 3

Antidepressant Medication for Reducing HIV Risk Behavior in Depressed Intravenous Drug Users

Completed
NCT00745017Phase 1

Stress Generation and Recurrent Depression: The Role of Differential Treatment Response

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6